Showing results (81-90 of 98) with videos related to
Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2018
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune SystemCristina Puig-Saus, Giulia Parisi, Angel Garcia-Diaz, et al.Blood|March 14, 2007
Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 geneCary Hsu, Stephanie A Jones, Cyrille J Cohen, et al.Blood Advances|April 20, 2026
Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell DiseaseChattip Prueksapraopong, Augustine Fernandes, Beatriz Campo Fernandez, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2015
[(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and FeasibilityLinda G Eissenberg, Michael P Rettig, Julie K Ritchey, et al.Human Gene Therapy|March 21, 2006
Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5Li Zhong, Weiming Li, Yanjun Li, et al.Molecular Therapy. Methods & Clinical Development|May 28, 2015
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitorOrit Wolstein, Maureen Boyd, Michelle Millington, et al.Human Gene Therapy|February 3, 2005
Impaired nuclear transport and uncoating limit recombinant adeno-associated virus 2 vector-mediated transduction of primary murine hematopoietic cellsLi Zhong, Weiming Li, Zuocheng Yang, et al.Molecular Therapy. Methods & Clinical Development|September 14, 2018
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository ExperienceKenneth Cornetta, Lisa Duffy, Steven A Feldman, et al.Science Translational Medicine|May 8, 2024
The translational gap for gene therapies in low- and middle-income countriesKevin W Doxzen, Jennifer E Adair, Yris Maria Fonseca Bazzo, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2013
Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiencyDenise A Carbonaro, Lin Zhang, Xiangyang Jin, et al.Pageof 10